Want to see CI full AI Analyst Report?
CI Stock Chart & Stats
$289.57
$3.28(1.15%)
At close: 4:00 PM EDT
$289.57
$3.28(1.15%)
Day’s Range― - ―
52-Week Range$239.51 - $315.47
Previous CloseN/A
Volume1.08M
Average Volume (3M)1.58M
Market Cap
$73.31B
Enterprise Value$104.94K
Total Cash (Recent Filing)$6.30B
Total Debt (Recent Filing)$31.88B
Price to Earnings (P/E)11.3
Beta0.26
Next Earnings
Oct 29, 2026EPS Estimate
7.52Next Dividend Ex-DateN/A
Dividend Yield2.24%
Share Statistics
EPS (TTM)24.25
Shares Outstanding264,240,480
10 Day Avg. Volume1,695,210
30 Day Avg. Volume1,576,466
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)1.75
Price to Sales (P/S)0.27
P/FCF Ratio8.73
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$346.00Price Target Upside19.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)30.5
Revenue Forecast (FY)$287.35B
Bulls Say, Bears Say
Bulls Say
Broad Revenue And Segment GrowthGrowth across both major segments indicates broad customer demand and expanding scale rather than reliance on a single business. Continued employer membership growth, specialty utilization and disciplined pricing can support durable revenue expansion.
Strong Cash Generation And Manageable LeverageHigh cash generation gives Cigna capacity to invest in services, reduce debt and return capital while absorbing operating volatility. Leverage is meaningful but manageable, and management expects debt-to-capitalization to move closer to 40%.
Technology And Clinical Cost AdvantagesMeasured clinical outcomes suggest technology can improve care coordination and lower medical spending, strengthening Cigna's value proposition to employers and members. Scaled adoption could improve retention, affordability and long-term operating efficiency.
Bears Say
Margin Compression And Earnings VariabilityRevenue growth has not translated consistently into stronger profitability, indicating exposure to medical costs, pharmacy economics and operating expenses. Persistent margin pressure could limit earnings quality and reduce flexibility during adverse utilization periods.
Elevated Medical Cost TrendsSustained high medical inflation can outpace pricing and underwriting assumptions, compressing insurance margins and requiring higher premiums. If utilization or provider costs accelerate, the pressure could persist beyond normal seasonal fluctuations.
PBS Transition And Structural Profit PressureThe PBS transition creates multi-period implementation costs and changes the economics of rebates and drug pricing. Although the model may support longer-term competitiveness, near-term earnings pressure and execution risk can weigh on segment profitability.
Cigna News
CI FAQ
What was Cigna’s price range in the past 12 months?
Cigna lowest stock price was $239.51 and its highest was $315.47 in the past 12 months.
What is Cigna’s market cap?
Cigna’s market cap is $73.31B.
When is Cigna’s upcoming earnings report date?
Cigna’s upcoming earnings report date is Oct 29, 2026 which is in 69 days.
How were Cigna’s earnings last quarter?
Cigna released its earnings results on Jul 30, 2026. The company reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.596 by $0.184.
Is Cigna overvalued?
According to Wall Street analysts Cigna’s price is currently Undervalued.
Does Cigna pay dividends?
Cigna pays a Quarterly dividend of $1.56 which represents an annual dividend yield of 2.24%. See more information on Cigna dividends here
What is Cigna’s EPS estimate?
Cigna’s EPS estimate is 7.52.
How many shares outstanding does Cigna have?
Cigna has 264,240,480 shares outstanding.
What happened to Cigna’s price movement after its last earnings report?
Cigna reported an EPS of $7.78 in its last earnings report, beating expectations of $7.596. Following the earnings report the stock price went down -2.972%.
Which hedge fund is a major shareholder of Cigna?
Currently, no hedge funds are holding shares in CI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cigna Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$346.00 (19.49% Upside)
$346.00 (19.49% Upside)
Blogger Sentiment
Bullish
CI Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $268.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.37%
12-Months-Change
Fundamentals
Return on Equity
2.24%
Trailing 12-Months
Asset Growth
3.90%
Trailing 12-Months
Company Description
Cigna
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
CI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum driven by specialty drug growth, Evernorth and Cigna Healthcare outperformance, AI-enabled clinical initiatives with measurable outcomes, solid revenue and EPS beats, and an upgraded full-year EPS outlook. Offsetting items include PBS earnings pressure from transition investments and economic shifts due to biosimilars, moderating GLP-1 utilization, persistently elevated medical cost trends, IDR-related affordability concerns, and one-time special charges. Overall, the positive drivers (revenue growth, margin gains in Specialty, upgraded guidance, retention/new-business strength, AI initiatives) materially outweigh the manageable challenges described.View all CI earnings summariesCI Stock 12 Month Forecast
Average Price Target
$346.00
▲(19.49% Upside)
Technical Analysis
Ownership Overview
0.34% Insiders
28.22% Mutual Funds
23.85% Other Institutional Investors
22.39% Public Companies and Individual Investors